Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 8 Gastrointestinal 4 Gynecologic 2 Tumor-Agnostic 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 101 Specimen Handling 83 pembrolizumab 76 enzalutamide 63 Nivolumab 59 Gemcitabine 56 Docetaxel 50 apalutamide 42 Radiosurgery 42 Abiraterone Acetate 40 Prednisone 39 Androgen Antagonists 39 Cisplatin 37 Biopsy 37 darolutamide 36 cabozantinib 32 Radiotherapy 32 Pluvicto 28 Carboplatin 28 abiraterone 27 Ipilimumab 25 enfortumab vedotin 24 durvalumab 24 Radiation 23 atezolizumab 22 X-Rays 21 Leuprolide 20 Standard of Care 19 olaparib 18 avelumab 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Testing × Genitourinary × 90 days × Clear all

NCT06632977 2026-06-02

PREDICT

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡